Covalon Technologies (Europe) Ltd is an established wound dressing supplier offering the advanced CovaWound™ dressing range.
Available to order through NHS Supply Chain, Drug Tariff, and other identified distributor partners across Europe, CovaWound™ is a proven quality, cost effective, wound care dressing range, specifically designed for the effective management of a wide range of chronic wounds.1,2
It currently costs the NHS a staggering 5 billion a year to treat chronic wounds.3 We recognise the rising pressures on both the NHS and healthcare professionals to reduce their wound dressing spend, and we believe that clinicians should be able to continue to offer the very best standards of care, despite those mounting cost pressures, which is why we introduced CovaWound™.
CovaWound™ is a proven quality, advanced wound care dressing range, which offers enhanced value compared to many market leading brands.1, 4 Designed with both ease of application and patient comfort in mind, CovaWound™ is suitable for the treatment of a wide range of chronic wounds.
CovaWound™ dressings are designed to manage exudate effectively, whilst protecting the peri-wound skin and providing an optimised wound healing environment. With over 70 different dressings available (varying in size, shape and design), the range offers versatility and choice, ensuring dressing selection can be matched to the individual patient’s need. Furthermore, a switch to CovaWound™ could mean significant savings for your clinic, hospital, NHS Trust or CCG.4
Discover how switching to CovaWound™ could benefit your hospital, NHS Trust or CCG. Contact the team today to find out.
Switching to CovaWound™ gives our customers the opportunity to invest the savings they make on their wound dressing spend into other, much needed resources, such as hospital equipment or even nursing staff. Clinicians tell us that switching to CovaWound™ is simple and hassle free, and our patients tell us that the dressings are comfortable and easy to manage.
Additionally, to keep prices as consistent as possible, at the point of use Covalon adopts a price parity model when selling CovaWound™ into all NHS supply routes including NHS Supply Chain and Drug Tariff. This helps to support our NHS customers in achieving an integrated pathway across both acute and community healthcare.
CovaWound™ dressings have undergone testing and evaluation both in the lab and independently by clinicians and patients, so you can be confident that CovaWound™ dressings support wound healing, whilst managing exudate effectively and providing excellent patient comfort.
CovaWound™ products are all CE certified. Dressing performance has been independently tested at the world-renowned Surgical Materials Testing Laboratory (SMTL), with results indicating parity and in some cases superiority to market leading brands.1
Ordering CovaWound™ is quick and easy so you can remain focused on the needs of your patients and be reassured that your CovaWound™ dressings will be available whenever you need them. We partner with leading healthcare distributors to ensure both fast and efficient distribution of CovaWound™.
In the UK the CovaWound™ range is available to order through Drug Tariff, NHS Supply Chain and Bunzl Healthcare. CovaWound™ is available through Lynch Medical in the Republic of Ireland and we work with a number of other healthcare distributors more widely across Europe.
We are happy to provide product samples to hospitals, CCGs, NHS Procurement teams, Podiatrists, Tissue Viability Nurses and other healthcare professionals working within wound care.
Covalon Technologies (Europe) Ltd would be delighted to talk with you about its' products, send you information on them, answer any questions you may have and keep you updated with it's developments. Please enter your contact details and click submit. Covalon Technologies (Europe) Ltd will not share your details with any other parties.
2. Clinical CovaWound™ Survey. Data held on file with further information available HERE
3. GUEST, J.F, AYOUB, N., MCLLWRAITH, T. et al (2017). Health economic burden that wounds impose on the National Health Service in the UK. Int Wound J, 14(2):322–30.
4. NHS Business Services Authority (2010) Drug Tariff. Available online at: http://www.drugtariff.nhsbsa.nhs.uk [accessed 31.10.19]
Covalon Technologies (Europe) Ltd, No 1 Mill, The Wharf, Shardlow, Derbyshire, DE72 2GH
T: +44 (0) 1332 322469